SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 305B2 - Filing [Trust Indenture Act]:
SEC Accession No. 0001193125-20-179489
Filing Date
2020-06-26
Accepted
2020-06-25 20:46:33
Documents
7
Effectiveness Date
2020-06-26

Document Format Files

Seq Description Document Type Size
1 305B2 d942243d305b2.htm 305B2 21156
2 EX-99.2 d942243dex992.htm EX-99.2 2468
3 EX-99.3 d942243dex993.htm EX-99.3 2622
4 EX-99.6 d942243dex996.htm EX-99.6 2387
5 EX-99.7 d942243dex997.htm EX-99.7 14439
6 GRAPHIC g942243ex2.jpg GRAPHIC 81238
7 GRAPHIC g942243ex3.jpg GRAPHIC 87360
  Complete submission text file 0001193125-20-179489.txt   276351
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 305B2 | Act: 33 | File No.: 333-233061 | Film No.: 20990936
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences